GlassScriptPhysician profile
Henry C Tsai
NPI 1710913876
$413,504.98
in general payments reported to CMS, 2019-2025
6 companies · $64K in 2025
The $64K reported for 2025 was more than what 98% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $55K · 2021: $71K · 2022: $72K · 2023: $64K · 2024: $87K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $205K · Travel and Lodging: $9,506 · Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $204,750.00 |
| Travel and Lodging | $9,505.59 |
| Food and Beverage | $857.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $412,973.64 | 2020-2025 | Alere Icup Dx Pro 2 |
| Pfizer INC. | $398.02 | 2020 | |
| Aveo Pharmaceuticals, INC. | $59.92 | 2021-2022 | |
| Tempus Ai, INC | $28.92 | 2024 | Xt Cdx |
| Coherus Oncology, INC. | $24.86 | 2023 | |
| Springworks Therapeutics, INC. | $19.62 | 2025 | Ogsiveo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.